Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer

Until recently, there had not been an effective systemic chemotherapy for advanced differentiated thyroid carcinoma (DTC); lenvatinib, a multi-tyrosine kinase inhibitor, has been proven effective for DTC, but has also been revealed to have adverse side effects including hypertension, hand-foot syndr...

Descripción completa

Detalles Bibliográficos
Autores principales: Suyama, Koichi, Fujiwara, Saori, Takeshita, Takashi, Sueta, Aiko, Inao, Touko, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492816/
https://www.ncbi.nlm.nih.gov/pubmed/28685069
http://dx.doi.org/10.3892/mco.2017.1265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492816/
https://www.ncbi.nlm.nih.gov/pubmed/28685069
http://dx.doi.org/10.3892/mco.2017.1265

Ejemplares similares